Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma

Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma

There is a need to improve the effectiveness of radiotherapy (RT) in hepatocellular carcinoma (HCC). Therefore, the purpose of this study was to explore the efficacy and toxicity of the anti-microtubule agent Vinorelbine as a radiosensitizer in HCC. The radio sensitivity of 16 HCC patient-derived xe...

Full description

Bibliographic Details
Main Authors: Kheng Wei Yeoh, Aldo Prawira, Muhammad Zafrie Bin Saad, Kok Ming Lee, Eric Ming Hon Lee, Gee Keng Low, Mohamed Hakim Bin Mohd Nasir, Jun Hao Phua, Wendy Wan Li Chow, Iris Jiu Hia Lim, Yusnita Binte Omar, Rebecca Zhi Wen Ho, Thi Bich Uyen Le, Thanh Chung Vu, Khee Chee Soo, Hung Huynh
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
hepatocellular carcinoma
radiotherapy
radio sensitization
vinorelbine
DNA repair
cost-effectiveness
Online Access:https://www.mdpi.com/2072-6694/12/4/872

Internet

https://www.mdpi.com/2072-6694/12/4/872

Similar Items